Single-cell RNA sequencing

#Cascade #Immune response #Nomic Bio #Parse Biosciences #Proteomics #QIAGEN #RNA sequencing #Single-cell RNA sequencing

Large-scale immune response dataset partnership

Proteomics company Nomic Bio and Parse Biosciences, a provider of single-cell sequencing and a QIAGEN company, have partnered to generate Cascade, a large-scale multimodal dataset designed to establish a foundational reference for healthy human immune response. Built using controlled perturbations across healthy donors, Cascade combines single-cell transcriptomic measurements with quantitative… Read More

#News

RNA
#Academic #Drug discovery #Single-cell analysis #Single-cell RNA sequencing

AI biotech company gives free access to single-cell sequencing

A new programme is offering academic researchers free access to advanced single-cell RNA sequencing to accelerate discovery across cancer and autoimmunity.  Immunai’s new academic initiative to support human immunology research is called the Immunai Grand Collaboration Initiative for Single-Cell Immune Profiling.  Through the programme, academic… Read More

#News

CRISPR gene editing
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

Webinar: How to achieve high-throughput single-cell sequencing

Join DDW for this free event, ‘CRISPR screening at scale: Achieving 1M cell data sets with an instrument-free, cost-effective approach‘, which is supported by Scale Biosciences. The event will take place on 25 April 5 PM BST / 6PM CEST / 9AM PST. Read More

Webinar date:
Brought to you by ScaleBio
#News

CRISPR gene editing
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening: Achieve 1 million data sets cost-effectively

Join DDW for this free event, ‘CRISPR screening at scale: Achieving 1M cell data sets with an instrument-free, cost-effective approach‘, which is supported by Scale Biosciences. The event will take place on 25 April 5 PM BST / 6PM CEST / 9AM PST. Read More

Webinar date:
Brought to you by ScaleBio
#News

CRISPR gene editing
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening: Achieving high-throughput single-cell sequencing

Join DDW for this free event, ‘CRISPR screening at scale: Achieving 1M cell data sets with an instrument-free, cost-effective approach‘, which is supported by Scale Biosciences. The event will take place on 25 April 5 PM BST / 6PM CEST / 9AM PST. Read More

Webinar date:
Brought to you by ScaleBio
#News

CRISPR-Cas9
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening at scale: A cost-effective approach

Join DDW for this free event, ‘CRISPR screening at scale: Achieving 1M cell data sets with an instrument-free, cost-effective approach‘, which is supported by Scale Biosciences. The event will take place on 25 April 5 PM BST / 6PM CEST / 9AM PST. Read More

Webinar date:
Brought to you by ScaleBio
#News

CRISPR-Cas9
#CRISPR #CRISPR screening #Drug discovery #Genetics / genomics #Single-cell RNA sequencing #Webinar

CRISPR screening at scale: Achieving 1m cell data sets with an instrument-free, cost-effective approach

Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel. Genome-wide screens are becoming the standard for drug discovery to power unbiased identification of drug targets across gene regulatory networks. Requiring single-cell… Read More

Webinar date:
Brought to you by ScaleBio
#Webinars

#3D chemistry #AI #Artificial intelligence (AI) #Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #Gene expression #Gene mutation #Interview #mRNA #Next generation sequencing #Oncology #PharmEnable #RNA sequencing #Single-cell RNA sequencing #Vaccines

Podcast: What trends will speed up the journey from clinic to bedside?

This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More

#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Event: Using native state cells to uncover true biological targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Why native state cells are needed to uncover true drug targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Webinar: How single-cell RNA seq has advanced drug discovery

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Human cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

An overview of single-cell RNA sequencing for drug discovery

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing #Webinar

Unperturbed, native state cells uncover biological targets

Extensive manipulation, mechanical force and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is the identification of drug targets that are not relevant to the biological process under study.  Camila Egidio Based on Nakhoda and Olszanski,… Read More

Webinar date:
Brought to you by LevitasBio
#News

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing

Broadening drug discovery: Use of unperturbed, native state cells to uncover true biological targets at single-cell level

Extensive manipulation, mechanical force, and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is identification of drug targets that are not relevant to the biological process under study. Based on Nakhoda and Olszanski, 2022 (Addressing Recent Failures… Read More

Webinar date:
Brought to you by LevitasBio
#Webinars

Next generation sequencing
#Gene expression #Gene mutation #Next generation sequencing #RNA sequencing #Single-cell RNA sequencing

Is single-cell gene expression the next trend in next generation sequencing? 

Listen to this article on the DDW podcast: By Dr Dina Finan, PhD, Product Manager at 10x Genomics and Dr Nick Downey, PhD, NGS Collaborations Lead at Integrated DNA Technologies.  RNA sequencing has become a widely used tool that can explore the transcriptome in a seemingly endless number of applications. While bulk sequencing—or… Read More

#Editor's Choice #Exclusive Content